Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Cancers|April 3, 2021
CTLA-4 in Regulatory T Cells for Cancer ImmunotherapyNavid Sobhani, Dana Rae Tardiel-Cyril, Aram Davtyan, et al.
Stem Cell Reviews and Reports|October 21, 2024
Patient-Derived Organoids: A Game-Changer in Personalized Cancer MedicineMohammad Hadi Abbasian, Navid Sobhani, Mahsa Mollapour Sisakht, et al.
Cancers|November 13, 2025
AI-Based Cancer Models in Oncology: From Diagnosis to ADC Drug PredictionNavid Sobhani, Fernanda G Kugeratski, Sergio Venturini, et al.
Experimental and Molecular Pathology|May 11, 2019
High GD2 expression defines breast cancer cells with enhanced invasivenessMaryam Mansoori, Raheleh Roudi, Ata Abbasi, et al.
Cancer Biomarkers : Section a of Disease Markers|October 23, 2014
Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancerRaheleh Roudi, Zahra Madjd, Alireza Korourian, et al.
Cell Biology International|October 14, 2022
RNA-sequencing for transcriptional profiling of whole blood in early stage and metastatic pancreatic cancer patientsSima Kalantari, Bahram Kazemi, Raheleh Roudi, et al.
Cancers|June 24, 2022
Predictive and Prognostic Value of Non-Coding RNA in Breast CancerNavid Sobhani, Richard Chahwan, Raheleh Roudi, et al.
Medicine|November 3, 2017
Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysisXiaoying Sun, Raheleh Roudi, Shangya Chen, et al.
BMJ Open|September 13, 2018
Do statins improve outcomes for patients with non-small cell lung cancer? A systematic review and meta-analysis protocolFeng Li, Guangyu Liu, Raheleh Roudi, et al.
International Journal of Experimental Pathology|May 16, 2019
Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancerElham Kalantari, Maryam Abolhasani, Raheleh Roudi, et al.
Pageof 7